Skip to main content

Table 2 Importance of unknown information during pre-screening for the four clinical trials of interest: importance of unknown information during pre-screening for the four clinical trials of interest

From: OWL model of clinical trial eligibility criteria compatible with partially-known information

  CT1 CT2 CT3 CT4
Nb inclusion fields 15 19 16 10
Nb exclusion fields 10 9 8 11
Nb common fields 3 0 2 3
Missing values 50.06% 61.72% 56.52% 42.99%
Nb patients with all inclusion fields known 0 0 1 1
Nb patients with all exclusion fields known 4 3 0 1
Nb patients with all fields known 0 0 0 0
Nb eligible patients 30 23 6 2